Dosing guidance for intravenous colistin in critically-ill patients.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background.: Intravenous colistin is difficult to use because plasma concentrations for antibacterial effect overlap those causing nephrotoxicity, and there is large interpatient variability in pharmacokinetics. The aim was to develop dosing algorithms for achievement of a clinically desirable average steady-state plasma colistin concentration (Css,avg) of 2 mg/L. Methods.: Plasma concentration-time data from 214 adult critically ill patients (creatinine clearance, 0–236 mL/min; 29 receiving renal replacement therapy [RRT]) were subjected to population pharmacokinetic analysis. Development of an algorithm for patients not receiving RRT was based on the relationship between the dose of colistimethate that would be needed to achieve a desired Css,avg and creatinine clearance. The increase in colistin clearance when patients were receiving RRT was determined from the population analysis and guided the supplemental dosing needed. To balance potential antibacterial benefit against risk of nephrotoxicity the algorithms were designed to achieve target attainment rates of >80% for Css,avg ≥2 and <30% for Css,avg ≥4 mg/L. Results.: When algorithm doses were applied back to individual patients not receiving RRT (including those prescribed intermittent dialysis on a nondialysis day), >80% of patients with creatinine clearance <80 mL/min achieved Css,avg ≥2 mg/L, but for patients with creatinine clearance ≥80 mL/min, the target attainment was <40%, even with the maximum allowed daily dose of 360 mg colistin base activity. For patients receiving RRT, target attainment rates were >80% with the proposed supplemental dosing. In all categories of patients, <30% of patients attained Css,avg ≥4 mg/L. Conclusions.: The project has generated clinician-friendly dosing algorithms and pointed to circumstances in which intravenous monotherapy may be inadequate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Self-citationGaronzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Self-citationSandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Self-citationColistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Self-citationPogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir611 · Cited by 327
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Nation, R. L., Velkov, T., & Li, J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu213 · Cited by 310
Self-citationSorlí, L., Luque, S., Grau, S., Berenguer, N., Segura, C., Montero, M. M., Álvarez-Lerma, F., Knobel, H., Benito, N., & Horcajada, J. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-380 · Cited by 225
Cheah, S.-E., Wang, J., Nguyen, V. T. T., Turnidge, J. D., Li, J., & Nation, R. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv267 · Cited by 206
Self-citationUpdated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Nation, R. L., Garonzik, S. M., Li, J., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Paterson, D. L., Turnidge, J. D., Forrest, A., & Silveira, F. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ964 · Cited by 168
Self-citationJelliffe, R. W. (2002) · American Journal of Nephrology · doi:10.1159/000065221 · Cited by 144
SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
Barnett, M., Bushby, S. R. M., & Wilkinson, S. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01610.x · Cited by 134
Li, J., Rayner, C. R., Nation, R. L., Deans, R., Boots, R. J., Widdecombe, N., Douglas, A., & Lipman, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4814-4815.2005 · Cited by 133
Self-citationKaraiskos, I., Friberg, L. E., Pontikis, K., Ioannidis, K., Tsagkari, V., Galani, L., Kostakou, E., Baziaka, F., Paskalis, C., Koutsoukou, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-15 · Cited by 113
Grégoire, N., Mimoz, O., Mégarbane, B., Comets, E., Chatelier, D., Lasocki, S., Gauzit, R., Balayn, D., Gobin, P., Marchand, S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03508-14 · Cited by 89
Karvanen, M., Plachouras, D., Friberg, L. E., Paramythiotou, E., Papadomichelakis, E., Karaiskos, I., Tsangaris, I., Armaganidis, A., Cars, O., & Giamarellou, H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00985-12 · Cited by 82
Horcajada, J. P., Sorlí, L., Luque, S., Benito, N., Segura, C., Campillo, N., Montero, M., Esteve, E., Mirelis, B., Pomar, V., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.020 · Cited by 70
Μάρκου, Ν., Fousteri, M., Markantonis, S. L., Zidianakis, B., Hroni, D., Boutzouka, E. G., & Baltopoulos, G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks257 · Cited by 68
Removal of colistin during intermittent haemodialysis in two critically ill patients
Marchand, S., Frat, J., Petitpas, F., Lemaitre, F., Gobin, P., Robert, R., Mimoz, O., & Couet, W. R. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq185 · Cited by 51
Jacobs, M., Grégoire, N., Mégarbane, B., Gobin, P., Balayn, D., Marchand, S., Mimoz, O., & Couet, W. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01868-15 · Cited by 49
Leporati, M., Bua, R. O., Mariano, F., Carignano, P., Stella, M., Biancone, L., & Vincenti, M. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182a8997c · Cited by 39
Karaiskos, I., Friberg, L. E., Galani, L., Ioannidis, K., Katsouda, E., Athanassa, Z., Paskalis, H., & Giamarellou, H. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.008 · Cited by 38
Jitmuang, A., Nation, R. L., Koomanachai, P., Chen, G., Lee, H. J., Vasuvattakul, S., Sritippayawan, S., Li, J., Thamlikitkul, V., & Landersdorfer, C. B. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv031 · Cited by 30
Self-citationMariano, F., Leporati, M., Carignano, P., Stella, M., Vincenti, M., & Biancone, L. (2014) · Journal of Nephrology · doi:10.1007/s40620-014-0143-3 · Cited by 25
Strunk, A.-K., Schmidt, J. J., Baroke, E., Bode‐Böger, S. M., Martens‐Lobenhoffer, J., Welte, T., & Kielstein, J. T. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku075 · Cited by 24
Luque, S., Sorlí, L., Li, J., Collado, S., Barbosa, F., Berenguer, N., Horcajada, J. P., & Grau, S. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000104 · Cited by 14
Self-citationCOLY‐MYCIN ® M PARENTERAL (Colistimethate for Injection)
Schlossberg, D., & Samuel, R. (2017) · Wiley eBooks · doi:10.1002/9781119220787.ch42 · Cited by 5
Research works printed but not linked: 2
- Forrest, Toxicodynamics for colistin-associated changes in creatinine clearance. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 5–9 September 2014
- European Medicines Agency, Annex III: amendments to relevant sections of the summary of product characteristics and the package leaflets
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Abdul-Aziz, M. H., Alffenaar, J.-W. C., Bassetti, M., Bracht, H., Dimopoulos, G., Marriott, D., Neely, M. N., Paiva, J.-A., Pea, F., Sjovall, F., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06050-1 · Cited by 1,081
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Self-citationHorcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Metadata
- Authors
- Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P.
- Affiliations
- Monash University (AU)
- School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo 3 ;
- Siriraj Hospital (TH)
- Fourth Department of Internal Medicine, University of Athens 6 Medical School ,
- University at Buffalo, State University of New York (US)
- The University of Queensland (AU)
- University of Pittsburgh Medical Center (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-23
- Volume
- 64
- Issue
- 5
- Pages
- 565-571
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5850520
- OpenAlex
- W2566638444
- Cited by
- 262
- References
- 27
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 18 · 2023: 17 · 2022: 31 · 2021: 27 · 2020: 42 · 2019: 42 · 2018: 27 · 2017: 23
- FWCI
- 24.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI070896)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- colistin, intravenous administration, dosing algorithm, critically ill patients, nephrotoxicity, population pharmacokinetics, creatinine clearance, renal replacement therapy, colistimethate, steady-state plasma concentration, antibiotic dosing
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Colistin, Female, Humans, Male, Middle Aged, Pilot Projects, Critical Illness, Practice Guidelines as Topic, Renal Replacement Therapy, Young Adult, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.